PubAg

Main content area

Pilot study utilizing Fluorine‐18 fluorodeoxyglucose‐positron emission tomography/computed tomography for glycolytic phenotyping of canine mast cell tumors

Author:
Griffin, Lynn R., Thamm, Doug H., Selmic, Laura E., Ehrhart, E.J., Randall, Elissa
Source:
Veterinary radiology & ultrasound 2018 v.59 no.4 pp. 461-468
ISSN:
1058-8183
Subject:
biopsy, computed tomography, dogs, glucose, glycolysis, histology, mast cells, metastasis, models, patients, phenotype, radiography
Abstract:
The goal of this prospective pilot study was to use naturally occurring canine mast cell tumors of various grades and stages as a model for attempting to determine how glucose uptake and markers of biologic behavior are correlated. It was hypothesized that enhanced glucose uptake, as measured by 2‐[fluorine‐18]fluoro‐d‐glucose‐positron emission tomography/computed tomography (F18 FDG PET‐CT), would correlate with histologic grade. Dogs were recruited for this study from a population referred for treatment of cytologically or histologically confirmed mast cell tumors. Patients were staged utilizing standard of care methods (abdominal ultrasound and three view thoracic radiographs), followed by a whole body F18 FDG PET‐CT. Results of the F18 FDG PET‐CT were analyzed for possible metastasis and standard uptake value maximum (SUVₘₐₓ) of identified lesions. Incisional or excisional biopsies of the accessible mast cell tumors were obtained and histology performed. Results were then analyzed to look for a possible correlation between the grade of mast cell tumors and SUVₘₐₓ. A total of nine animals were included in the sample. Findings indicated that there was a correlation between grade of mast cell tumors and SUVₘₐₓ as determined by F18 FDG PET‐CT (p‐value = 0.073, significance ≤ 0.1). Based on the limited power of this study, it is felt that further research to examine the relationship between glucose utilization and biologic aggressiveness in canine mast cell tumors is warranted. This study was unable to show that F18 FDG PET‐CT was a better staging tool than standard of care methods.
Agid:
6009008